Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Alcohol Alcohol ; 47(5): 501-8, 2012.
Article in English | MEDLINE | ID: mdl-22791370

ABSTRACT

AIMS: Animal studies suggest that in alcohol withdrawal the balance of neurotransmitters gamma aminobutyric acid (GABA) and glutamate is altered. To test this in humans, we aimed to measure plasma levels of glutamate, GABA and glutamate/GABA ratio in alcoholic patients presenting with complicated AWS with the same values in non-alcohol abuser/dependent controls and to determine prognostic factors for severe withdrawal. METHODS: 88 patients admitted to the emergency room for acute alcohol intoxication (DSM-IV) were prospectively included. Measurements of GABA and glutamate were performed on admission (Time 1, T1) and after 12 ± 2 h (T2). The experimental group (EG) was composed of 23 patients who presented at T2 with a severe AWS. The control group (CG) consisted of healthy subjects paired with the EG (gender and age). Logistic regression was performed in order to compare associated clinical and biological variables that could predict severe withdrawal. RESULTS: The concentration of GABA in the EG at T1 was significantly lower than that in the CG. The concentration of glutamate in the EG at T1 was significantly higher than that in the CG. The glutamate/GABA ratio in the EG at T1 was significantly higher than the ratio in the CG. With a multivariate logistic regression model, glutamate level at admission remained the only criterion identified as a predictor of AWS at 12 h. CONCLUSION: Decreased synthesis of GABA and increased synthesis of glutamate might be related to withdrawal symptoms experienced on brutal cessation of chronic alcohol intake.


Subject(s)
Central Nervous System Depressants/adverse effects , Ethanol/adverse effects , Glutamic Acid/metabolism , Substance Withdrawal Syndrome/metabolism , gamma-Aminobutyric Acid/metabolism , Adult , Alcoholic Intoxication/blood , Alcoholic Intoxication/metabolism , Alcoholism/blood , Alcoholism/metabolism , Case-Control Studies , Central Nervous System Depressants/blood , Ethanol/blood , Female , Glutamic Acid/blood , Humans , Male , Middle Aged , Prospective Studies , Substance Withdrawal Syndrome/blood , gamma-Aminobutyric Acid/blood
3.
Alcohol Alcohol ; 47(3): 273-81, 2012.
Article in English | MEDLINE | ID: mdl-22414922

ABSTRACT

AIMS: A number of screening instruments are routinely used in Emergency Department (ED) situations to identify alcohol-use disorders (AUD). We wished to study the psychometric features, particularly concerning optimal thresholds scores (TSs), of four assessment scales frequently used to screen for abuse and/or dependence, the cut-down annoyed guilty eye-opener (CAGE), Rapid Alcohol Problem Screen 4 (RAPS4), RAPS4-quantity-frequency and AUD Identification Test (AUDIT) questionnaires, particularly in the sub-group of people admitted for acute alcohol intoxication (AAI). METHODS: All included patients [AAI admitted to ED (blood alcohol level ≥0.8 g/l)] were assessed by the four scales, and with a gold standard (alcohol dependence/abuse section of the Mini International Neuropsychiatric Interview), to determine AUD status. To investigate the TSs of the scales, we used Youden's index, efficiency, receiver operating characteristic (ROC) curve techniques and quality ROC curve technique for optimized TS (indices of quality). RESULTS: A total of 164 persons (122 males, 42 females) were included in the study. Nineteen (11.60%) were identified as alcohol abusers alone and 128 (78.1%) as alcohol dependents (DSM-IV). Results suggest a statistically significant difference between men and women (P < 0.05) in performance of the screening tests RAPS4 (≥1) and CAGE (≥2) for detecting abuse. Also, in this population, we show an increase in TSs of RAPS4 (≥2) and CAGE (≥3) for detecting dependence compared with those typically accepted in non-intoxicated individuals. The AUDIT test demonstrates good performance for detecting alcohol abuse and/or alcohol-dependent patients (≥7 for women and ≥12 for men) and for distinguishing alcohol dependence (≥11 for women and ≥14 for men) from other conditions. CONCLUSION: Our study underscores for the first time the need to adapt, taking into account gender, the thresholds of tests typically used for detection of abuse and dependence in this population.


Subject(s)
Alcoholic Intoxication , Alcoholism/diagnosis , Mass Screening/methods , Adult , Emergency Service, Hospital , Female , Humans , Male , Middle Aged , Psychometrics/instrumentation , ROC Curve , Sensitivity and Specificity , Sex Factors , Surveys and Questionnaires
4.
Nature ; 413(6855): 479, 2001 Oct 04.
Article in English | MEDLINE | ID: mdl-11586348

ABSTRACT

Sophisticated examples of European palaeolithic parietal art can be seen in the caves of Altamira, Lascaux and Niaux near the Pyrenees, which date to the Magdalenian period (12,000-17,000 years ago), but paintings of comparable skill and complexity were created much earlier, some possibly more than 30,000 years ago. We have derived new radiocarbon dates for the drawings that decorate the Chauvet cave in Vallon-Pont-d'Arc, Ardèche, France, which confirm that even 30,000 years ago Aurignacian artists, already known as accomplished carvers, could create masterpieces comparable to the best Magdalenian art. Prehistorians, who have traditionally interpreted the evolution of prehistoric art as a steady progression from simple to more complex representations, may have to reconsider existing theories of the origins of art.


Subject(s)
Paintings/history , Archaeology , Biological Evolution , France , History, Ancient , Humans
5.
J Genet Hum ; 37(4-5): 315-9, 1989 Dec.
Article in French | MEDLINE | ID: mdl-2517561

ABSTRACT

We report on two cases of children suffering from biopterin synthetase deficiency. Both were treated with the same treatment schedule with biopterin and neurotransmitters: 6-hydroxytryptophan and dihydrophenylalanine (DOPA). The only difference between the two cases is the time of diagnosis and therefore of treatment. The child who was treated early has a normal neurologic development. The other one has been treated since he was 7 months old and is mentally deficient (DQ = 0.60). This older child also suffers from dystonia probably secondary to Levodopa treatment. The authors emphasize the uncertainty of these patient's evolution owing to complications of the disease itself or those due to prolonged treatment by neurotransmitters.


Subject(s)
Alcohol Oxidoreductases/deficiency , 5-Hydroxytryptophan/therapeutic use , Age Factors , Biopterins/therapeutic use , Dihydroxyphenylalanine/therapeutic use , Female , Humans , Male , Phenylalanine Hydroxylase/deficiency
SELECTION OF CITATIONS
SEARCH DETAIL
...